|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1-2
|
|
pubmed:dateCreated |
1995-10-12
|
|
pubmed:abstractText |
Bazex paraneoplastic acrokeratosis remains a therapeutic challenge when the cancer cannot be treated. We report the third patient in which a complete clearance of the lesions was obtained with oral acitretine.
|
|
pubmed:language |
fre
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0151-9638
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
122
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
26-9
|
|
pubmed:dateRevised |
2010-3-24
|
|
pubmed:meshHeading |
|
|
pubmed:year |
1995
|
|
pubmed:articleTitle |
[Bazex paraneoplastic acrokeratosis. Treatment with acitretin].
|
|
pubmed:affiliation |
Service de Dermatologie, Hôpital Robert-Debré, Reims.
|
|
pubmed:publicationType |
Journal Article,
English Abstract,
Case Reports
|
